Keene & Associates, Inc. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 244 filers reported holding HAEMONETICS CORP in Q2 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
Keene & Associates, Inc. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$762,505
+8.4%
8,512
+3.0%
0.61%
+12.1%
Q2 2023$703,427
-4.0%
8,262
-6.7%
0.55%
-3.9%
Q1 2023$732,834
+6.1%
8,856
+0.8%
0.57%
-7.9%
Q4 2022$690,862
-8.3%
8,784
-13.7%
0.62%
-10.8%
Q3 2022$753,000
-4.3%
10,174
-15.7%
0.69%
-6.1%
Q2 2022$787,000
-8.1%
12,073
-10.8%
0.74%
+5.6%
Q1 2022$856,000
+37.6%
13,534
+15.5%
0.70%
+30.0%
Q4 2021$622,00011,7200.54%
Other shareholders
HAEMONETICS CORP shareholders Q2 2022
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders